ATE234355T1 - Gaba-a rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte zellen, die diese expremieren - Google Patents

Gaba-a rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte zellen, die diese expremieren

Info

Publication number
ATE234355T1
ATE234355T1 AT92911528T AT92911528T ATE234355T1 AT E234355 T1 ATE234355 T1 AT E234355T1 AT 92911528 T AT92911528 T AT 92911528T AT 92911528 T AT92911528 T AT 92911528T AT E234355 T1 ATE234355 T1 AT E234355T1
Authority
AT
Austria
Prior art keywords
alpha
beta
gaba
express
transfected cells
Prior art date
Application number
AT92911528T
Other languages
English (en)
Inventor
Karen Louise Hadingham
Bourdelles Beatrice Le
Paul John Whiting
Peter Baxter Wingrove
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE234355T1 publication Critical patent/ATE234355T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Semiconductor Memories (AREA)
  • Semiconductor Lasers (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
AT92911528T 1991-06-11 1992-06-09 Gaba-a rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte zellen, die diese expremieren ATE234355T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919112504A GB9112504D0 (en) 1991-06-11 1991-06-11 Cell line
PCT/GB1992/001031 WO1992022652A1 (en) 1991-06-11 1992-06-09 GABA-A RECEPTOR SUBUNITS (α-2, α-3, α-5, α-6, β-2) AND TRANSFECTED CELLS EXPRESSING THEM

Publications (1)

Publication Number Publication Date
ATE234355T1 true ATE234355T1 (de) 2003-03-15

Family

ID=10696436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911528T ATE234355T1 (de) 1991-06-11 1992-06-09 Gaba-a rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte zellen, die diese expremieren

Country Status (10)

Country Link
EP (2) EP0589930B1 (de)
JP (1) JPH06508023A (de)
AT (1) ATE234355T1 (de)
AU (1) AU663090B2 (de)
CA (1) CA2109193C (de)
DE (1) DE69232953T2 (de)
DK (1) DK0589930T3 (de)
ES (1) ES2192554T3 (de)
GB (1) GB9112504D0 (de)
WO (1) WO1992022652A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333923T2 (de) * 1992-12-10 2006-08-03 Merck Sharp & Dohme Ltd., Hoddesdon Stabil transfizierte Zelllinien welche Gaba-A- Rezeptoren mit der Untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren
GB9408064D0 (en) * 1994-04-22 1994-06-15 Merck Sharp & Dohme Nucleic acids
US5527703A (en) * 1994-05-25 1996-06-18 Merck & Co., Inc. DNA encoding glutamate gated chloride channels
GB9420010D0 (en) 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
US5693492A (en) * 1995-05-05 1997-12-02 Merck & Co., Inc. DNA encoding glutamate gated chloride channels
GB9715164D0 (en) * 1997-07-19 1997-09-24 Medical Res Council Improvements in or relating to expression of nucleic acid sequences in cerebellar cells
US6358701B1 (en) 1997-08-11 2002-03-19 Merck & Co., Inc. DNA molecules encoding Ctenocephalides felis glutamate gated chloride channels
US20060141528A1 (en) * 2004-05-21 2006-06-29 Aebersold Rudolf H Compositions and methods for quantification of serum glycoproteins
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CN106854207B (zh) 2015-12-08 2019-10-29 上海赛默罗生物科技有限公司 呔嗪类衍生物、其制备方法、药物组合物和用途
US11512089B2 (en) 2018-03-12 2022-11-29 Shanghai SIMR Biotechnology Co., Ltd Substituted [1,2,4]triazolo[3,4-a]phthalazines as modulators of GABAA receptor activity
CN112979655A (zh) 2019-12-16 2021-06-18 上海赛默罗生物科技有限公司 三唑并哒嗪类衍生物、其制备方法、药物组合物和用途
AU2022327398A1 (en) 2021-08-12 2024-03-21 Shanghai SIMR Biotechnology Co., Ltd Substituted triazole derivative, preparation method therefor, pharmaceutical composition thereof, and use thereof
CN116854680A (zh) 2022-03-28 2023-10-10 上海赛默罗生物科技有限公司 异噁唑-杂环类衍生物、药物组合物和用途

Also Published As

Publication number Publication date
GB9112504D0 (en) 1991-07-31
DK0589930T3 (da) 2003-04-22
WO1992022652A1 (en) 1992-12-23
DE69232953T2 (de) 2003-12-11
AU663090B2 (en) 1995-09-28
EP0589930A1 (de) 1994-04-06
EP1258530A2 (de) 2002-11-20
AU1921192A (en) 1993-01-12
EP0589930B1 (de) 2003-03-12
EP1258530A3 (de) 2002-11-27
JPH06508023A (ja) 1994-09-14
CA2109193C (en) 2003-04-08
CA2109193A1 (en) 1992-12-12
DE69232953D1 (de) 2003-04-17
ES2192554T3 (es) 2003-10-16

Similar Documents

Publication Publication Date Title
ATE234355T1 (de) Gaba-a rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte zellen, die diese expremieren
Naasan et al. Conventional glass ionomers as posterior restorations. A status report for the American Journal of Dentistry.
Bichacho et al. Single implant restorations: prosthetically induced soft tissue topography.
LU88738I2 (fr) Hormone Folliculo-Stimulante humaine recombinante (follitropine alpha) et ses dérivés pharmaceutiquement acceptables GONAL-F
ATE311449T1 (de) Stabil transfizierte zelllinien welche gaba-a- rezeptoren mit der untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren
Hickel et al. A comparison of glass cermet cement and amalgam restorations in primary molars.
Krejci et al. Adhesive crowns and fixed partial dentures fabricated of ceromer/FRC: clinical and laboratory procedures.
CA2148599A1 (en) Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them
Esquivel-Upshaw et al. Ceramic design concepts based on stress distribution analysis.
Evans et al. Craniofacial osseointegration of a large midfacial bone-anchored combination maxillofacial prosthesis: a clinical report.
Hunt et al. Evolution of post and core systems.
Pary Psychoactive drugs used with adults and elderly adults who have mental retardation.
Weber et al. Hard-tissue augmentation for the placement of anterior dental implants.
Mason et al. Single-dose metrifonate for the treatment of Schistosoma haematobium infection in an endemic area of Zimbabwe.
EP0659217A4 (de) KLONIERUNG UND EXPRESSION VON DEM -g(b)APP-C100 REZEPTOR.
DK0977848T3 (da) Human theta-underenhed af GABA-A-receptoren
Dworkin Glossectomy: a case report.
Fujisawa et al. Bone matrix proteins
Tanaka Fundamental study on occlusal wear of high-strength resin posterior denture teeth
Ivanova Effect of testosterone on the rate of synthesis of cytoplasmic and nuclear proteins in the reproductive tract of rabbit embryos in vitro
Kawazu et al. Periodontal disease and implant-supported prostheses
Spiechowicz et al. Remote results of prosthetic treatment of patients with nickel hypersensitivity
Meissner et al. Therapy of class V cavities
Razzoog et al. Guidelines for professional quality dentures for the financially disadvantaged.
Uner et al. Role of odontomas on eruption difficulties of permanent teeth and surgical-orthodontical approach

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties